Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.990
+0.040 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
Cryo-Cell International Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Cryo-Cell International.
Price Target: $0.00 (0.00%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Cryo-Cell International is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 20, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $9 → $8.5 | Strong Buy | Maintains | $9 → $8.5 | +113.03% | Mar 4, 2025 |
| Maxim Group | Maxim Group | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +200.75% | Aug 29, 2022 |
Financial Forecast
Revenue This Year
32.08M
from 31.99M
Increased by 0.30%
Revenue Next Year
30.52M
from 32.08M
Decreased by -4.87%
EPS This Year
0.11
from 0.05
Increased by 126.88%
EPS Next Year
-0.43
from 0.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 33.0M | 31.4M |
| Avg | 32.1M | 30.5M |
| Low | 30.8M | 29.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 3.3% | -2.1% |
| Avg | 0.3% | -4.9% |
| Low | -3.6% | -8.6% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.12 | -0.44 |
| Avg | 0.11 | -0.43 |
| Low | 0.11 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 133.6% | - |
| Avg | 126.9% | - |
| Low | 118.0% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.